论文部分内容阅读
1978年4月初,美国Furman医师及美国起搏器公司Mosharrafa工程师来沪访问,4月6日及7日做了学术报告并进行了座谈,现将内容摘要介绍如下。Furman医师:我先介绍起搏器在临床方面的应用情况。我们认为各种心律失常均可安装起搏器,但总的来说,安装起搏器的适应症随着起搏器工艺发展而有所改变。从1958年我们开始安装起搏器以后,最经典的指征是完全性房室传导阻滞,在开始时几乎占100%。但至1975年从我院安装起搏器的统计资料表明,完全性房室传导阻滞的百分率仅占17.9%,其他如病态窦房结综合征、间歇性房室传导阻滞、房颤伴有室率缓慢(指室率<50次/分)、预激症候群、药物
In early April 1978, Dr. Furman, a physician from the United States, and Mosharrafa engineer from the American Pacemaker Company came to Shanghai for an academic report and discussed on April 6 and 7, and the abstract is as follows. Furman: First, I introduce the clinical application of pacemaker. We think pacemakers are available for a variety of arrhythmias, but in general, the pacemaker-mounted indications change as the pacemaker process evolves. After we started the pacemaker installation in 1958, the most classic indication was complete atrioventricular block, which initially accounted for almost 100%. However, in 1975, the statistics of pacemakers installed in our hospital showed that the percentage of complete atrioventricular block was only 17.9%. Others such as sick sinus syndrome, intermittent atrioventricular block, atrial fibrillation Room rate is slow (refers to room rate <50 beats / min), pre-shock syndrome, drugs